A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome

Journal of Occupational and Environmental Medicine

Volumn 46, Issue 7, 2004, Pages 649-656

  Dean, Bonnie B ^a,c   Borenstein, Jeff E ^b  

^a Cerner Health Insights   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DAILY RATING OF SEVERITY PROBLEMS FORM; FEMALE; HOUSEHOLD; HUMAN; HUMAN RELATION; LEISURE; LIFE IMPAIRMENT; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MENSTRUAL CYCLE; PREMENSTRUAL SYNDROME; PRODUCTIVITY; QUESTIONNAIRE; SCHOOL; SELF REPORT; SOCIAL BEHAVIOR; SYMPTOMATOLOGY;

ABSENTEEISM; ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; EMPLOYMENT; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; MIDDLE AGED; PREMENSTRUAL SYNDROME; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; WORKPLACE;

EID: 3142664613     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000131796.62115.84     Document Type: Article

References (29)

1. Hammarback S, Backstrom T. A demographic study in subgroups of women seeking help for premenstrual syndrome. Acta Obstet Gynecol Scand. 1989;68:247-253.
2. Rapkin AJ, Chang LC, Reading AE. Comparison of retrospective and prospective assessment of premenstrual symptoms. Psychol Rep. 1988;62:55-60.
3. Korzekwa MI, Steiner M. Premenstrual syndromes. Clin Obstet Gynecol. 1997; 40:564-576.
4. Pearlstein T, Stone AB. Premenstrual syndrome. Psychiatr Clin North Am. 1998;21:577-590.
5. Hylan TR, Sundell K, Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France. J Womens Health Gend Based Med. 1999; 8:1043-1052.
6. Johnson SR. The epidemiology and social impact of premenstrual symptoms. Clin Obstet Gynecol. 1987;30:367-376.
7. Campbell EM, Peterkin D, O'Grady K, Sanson-Fisher R. Premenstrual symptoms in general practice patients. Prevalence and treatment. J Reprod Med. 1997; 42:637-646.
8. Deuster PA, Adera T, South-Paul J. Biological, social, and behavioral factors associated with premenstrual syndrome. Arch Fam Med. 1999;8:122-128.
9. Robinson RL, Swindle RW. Premenstrual symptom severity: impact on social functioning and treatment-seeking behaviors. J Womens Health Gend Based Med. 2000;9:757-768.
10. Ramcharan S, Love EJ, Fick GH, Goldfien A. The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors. J Clin Epidemiol. 1992;45:377-392.
11. Rivera-Tovar AD, Frank E. Late luteal phase dysphoric disorder in young women. Am J Psychiatry. 1990;147:1634-1636.
12. Andersch B, Hahn L. [Premenstrual complaints. Influence of oral contraceptives (author's transl)]. Contracept Fertil Sex (Paris). 1982;10:659-664.
13. Ekholm UB, Backstrom T. Influence of premenstrual syndrome on family, social life, and work performance. Int J Health Serv. 1994;24:629-647.
14. Hallman J. The premenstrual syndrome-an equivalent of depression? Acta Psychiatr Scand. 1986;73:403-411.
15. Endicott J, Harrison W. Daily Rating of Severity of Problems Form. New York: Department of Research Assessment and Training, New York Psychiatric Institute; 1990.
16. Yonkers KA, Halbreich U, Freeman E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. JAMA. 1997; 983-988.
17. Borenstein JE, Dean BB, Endicott J, et al. Health and economic impact of the premenstrual syndrome. J Reprod Med. 2003;48:515-524.
18. Chawla A, Swindle R, Long S, Kennedy S, Sternfeld B. Premenstrual dysphoric disorder: is there an economic burden of illness? Med Care. 2002;40:1101-1112.
19. Mortola JF, Girton L, Beck L, Yen SS. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol. 1990;76:302-307.
20. Warshaw LJ, Burton WN. Cutting the costs of migraine: role of the employee health unit. J Occup Environ Med. 1998; 40:943-953.
21. Meltzer EO. An overview of current pharmacotherapy in perennial rhinitis. J Allergy Clin Immunol. 1995;95:1097-1110.
22. Conti DJ, Burton WN. The economic impact of depression in a workplace. J Occup Med. 1994;36:983-988.
23. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA. 1998;1490-1496.
24. Rizzo JA, Abbott TA III, Pashko S. Labour productivity effects of prescribed medicines for chronically ill workers. Health Econ. 1996;5:249-265.
25. Greenberg PE, Finkelstein SN, Berndt ER. Economic consequences of illness in the workplace. Sloan Manage Rev. 1995; 36:26-38.
26. Wahlqvist P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am J Gastroenterol. 2001;96:S57-S61.
27. Bloom BS, Jayadevappa R, Wahl P, Cacciamanni J. Time trends in cost of caring for people with gastroesophageal reflux disease. Am J Gastroenterol. 2001;96:S64-S69.
28. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569-1580.
29. Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther. 1997;11:553-559.